Yep. I don't doubt it. It's just not coming across in the announcements.
How can a phase 3 oncology pharma with very strong indications of also having therapeutic effect have a MC of less than 30M?
Answer - delays and poor communications.
- Forums
- ASX - By Stock
- Ann: Shareholder Update - Progress and Strategy
Yep. I don't doubt it. It's just not coming across in the...
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $94.89M |
Open | High | Low | Value | Volume |
20.0¢ | 20.3¢ | 19.5¢ | $124.5K | 628.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2791 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 62424 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2791 | 0.195 |
9 | 239472 | 0.190 |
5 | 341026 | 0.185 |
6 | 354777 | 0.180 |
4 | 120797 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 62424 | 2 |
0.205 | 4800 | 1 |
0.210 | 82780 | 3 |
0.215 | 206338 | 3 |
0.225 | 34130 | 2 |
Last trade - 15.39pm 01/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |